Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
EL.En. S.p.A. (ELN.MI)
EUR16.49
+0.09 (+0.55%)
IT MIL Healthcare Medical - Devices
Address
Via Baldanzese 17 50041
Calenzano, FI, IT
Calenzano, FI, IT
CEO
Gabriele Clementi
Website
elengroup.com
IPO
2000-12-11
ISIN IT0005453250
Also trades on
Italian Stock Exchange · ELN.MI (EUR)
Other OTC · ELEAF (USD)
Description
EL.En. S.p.A. is a global leader in the development, manufacturing, marketing, and distribution of advanced laser systems. The company supplies a wide array of medical laser equipment for applications in physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art. Additionally, EL.En. offers industrial laser sources and integrated systems engineered for precise cutting, welding, marking, and engraving across numerous materials. Its product portfolio includes various laser source technologies, such as liquid, solid-state, semiconductor, and gas lasers. Complementing its product offerings, the company provides comprehensive after-sales services, including spare parts supply, expert consultation, and technical support. Established in 1981, EL.En. S.p.A. is headquartered in Calenzano, Italy.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR16.49
+0.09 (+0.55%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
73.6K
Beta
1.09
Float Shares
46.53M
Free Float %
58.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.21% | +2.03% | +15.47% | +6.20% | +18.37% | +8.02% | +38.35% | +40.15% | +43.62% | +381.79% | +860.51% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
16.49
DCF (Unlevered)
9.13
-44.6%
DCF (Levered)
8.01
-51.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.43
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+4.4% Q1'26: +3.3% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-15.6% Q1'26: +25.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+14.1% Q1'26: +39.2% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+13.2% ★ Q1'26: +13.6% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+20.9% ★ Q1'26: +31.3% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%0.0% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.41× ★ Q1'26: 0.40× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
217.67M
est: 214.48M (+1.5%)
|
252.65M
est: 245.14M (+3.1%)
|
306.46M
est: 301.63M (+1.6%)
|
346.02M
est: 341.04M (+1.5%)
|
400.76M
est: 398.96M (+0.5%)
|
408.08M
est: 375.90M (+8.6%)
|
571.40M
est: 565.00M (+1.1%)
|
673.58M
est: 672.14M (+0.2%)
|
692.29M
est: 659.63M (+5.0%)
|
565.85M
est: 668.82M (-15.4%)
|
590.85M
est: 586.98M (+0.7%)
|
625.98M
622.56M – 629.86M
+6.6% YoY
|
668.08M
661.04M – 676.08M
+6.7% YoY
|
711.82M
707.93M – 716.24M
+6.5% YoY
|
| EBITDA |
24.53M
est: 28.02M (-12.5%)
|
31.17M
est: 32.02M (-2.7%)
|
32.44M
est: 39.40M (-17.7%)
|
36.07M
est: 44.55M (-19.0%)
|
45.83M
est: 52.11M (-12.1%)
|
37.18M
est: 49.10M (-24.3%)
|
76.59M
est: 73.80M (+3.8%)
|
90.71M
est: 87.80M (+3.3%)
|
83.94M
est: 94.87M (-11.5%)
|
97.35M
est: 96.19M (+1.2%)
|
92.83M
est: 84.42M (+10.0%)
|
90.03M
89.54M – 90.59M
+6.6% YoY
|
96.08M
95.07M – 97.23M
+6.7% YoY
|
102.38M
101.82M – 103.01M
+6.5% YoY
|
| EBIT |
23.70M
est: 24.25M (-2.3%)
|
53.13M
est: 27.71M (+91.7%)
|
27.52M
est: 34.10M (-19.3%)
|
29.71M
est: 38.56M (-23.0%)
|
38.94M
est: 45.10M (-13.7%)
|
29.28M
est: 42.50M (-31.1%)
|
67.88M
est: 63.88M (+6.3%)
|
80.63M
est: 75.99M (+6.1%)
|
72.10M
est: 82.48M (-12.6%)
|
85.38M
est: 83.63M (+2.1%)
|
77.80M
est: 73.40M (+6.0%)
|
78.27M
77.85M – 78.76M
+6.6% YoY
|
83.54M
82.66M – 84.54M
+6.7% YoY
|
89.01M
88.52M – 89.56M
+6.5% YoY
|
| Net Income |
14.37M
est: 13.81M (+4.1%)
|
40.41M
est: 15.83M (+155.3%)
|
15.63M
est: 18.72M (-16.5%)
|
16.79M
est: 18.82M (-10.8%)
|
26.02M
est: 24.30M (+7.1%)
|
20.26M
est: 18.45M (+9.8%)
|
45.44M
est: 46.15M (-1.5%)
|
55.11M
est: 56.86M (-3.1%)
|
48.24M
est: 49.76M (-3.1%)
|
51.61M
est: 53.51M (-3.6%)
|
43.41M
est: 50.68M (-14.3%)
|
58.65M
58.64M – 65.10M
+15.7% YoY
|
64.15M
63.43M – 70.82M
+9.4% YoY
|
69.05M
66.96M – 73.86M
+7.6% YoY
|
| SGA |
10.26M
est: 15.20M (-32.5%)
|
11.19M
est: 17.37M (-35.6%)
|
12.14M
est: 21.38M (-43.2%)
|
15.37M
est: 24.17M (-36.4%)
|
15.54M
est: 28.27M (-45.0%)
|
10.61M
est: 26.64M (-60.2%)
|
12.50M
est: 40.04M (-68.8%)
|
16.95M
est: 47.63M (-64.4%)
|
167.48M
est: 56.69M (+195.4%)
|
22.28M
est: 57.48M (-61.2%)
|
59.88M
est: 50.44M (+18.7%)
|
53.80M
53.50M – 54.13M
+6.6% YoY
|
57.41M
56.81M – 58.10M
+6.7% YoY
|
61.17M
60.84M – 61.55M
+6.5% YoY
|
| EPS |
0.19
est: 0.17 (+10.3%)
|
0.52
est: 0.20 (+163.2%)
|
0.20
est: 0.23 (-14.4%)
|
0.22
est: 0.23 (-6.4%)
|
0.34
est: 0.30 (+12.1%)
|
0.26
est: 0.23 (+12.9%)
|
0.57
est: 0.58 (-1.0%)
|
0.69
est: 0.71 (-2.7%)
|
0.60
est: 0.62 (-4.0%)
|
0.64
est: 0.67 (-4.6%)
|
0.54
est: 0.63 (-14.1%)
|
0.77
0.73 – 0.81
+22.1% YoY
|
0.84
0.79 – 0.88
+9.0% YoY
|
0.88
0.84 – 0.92
+5.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
91.01M
OE per share TTM
1.13
Owner's Yield
7.53%
Maintenance CapEx ratio
111.47%
Maint CapEx / Avg PPE
16.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 66 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.23% | 214.6K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.23% | 214.6K | 0.38% |
| 3 | WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc WTIM.DE | 0.21% | 119.1K | 0.29% |
| 4 | WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR EGRW.L | 0.21% | 119.1K | 0.29% |
| 5 | WisdomTree Europe Equity UCITS ETF - EUR Acc WTDF.DE | 0.16% | 202.3K | 0.32% |
| 6 | WisdomTree Europe Equity UCITS ETF - USD Hedged Acc HEDK.L | 0.16% | 177.6K | 0.58% |
| 7 | WisdomTree Europe Equity UCITS ETF - USD Hedged HEDJ.L | 0.16% | 177.6K | 0.58% |
| 8 | WisdomTree Europe Equity UCITS ETF - GBP Hedged HEDP.L | 0.16% | 237.6K | 0.35% |
| 9 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.15% | 1.12M | 0.33% |
| 10 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.15% | 1.56M | 0.58% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
37.4K
Shares Outstanding
80.14M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gabriele Clementi | President, Chief Executive Officer & Director | 615.7K | male |
| Andrea Cangioli | MD & Executive Director | 556.0K | — |
| Enrico Romagnoli | Investor Relations Manager, Manager of the Financial Department & Executive Officer | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ELN.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
